Compound ID | 1056
Class: Glycopeptide
Spectrum of activity: | Gram-positive |
Details of activity: | Similar in mechanism of action to vancomycin |
Combined with other compounds: | No |
Propensity to select resistant mutants: | No |
Institute where first reported: | The Lilly Research Laboratories |
Year first mentioned: | 1977 |
Highest developmental phase: | Preclinical |
Development status: | Inactive |
External links: | |
Citations: |
|